Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Informa Pharma Intelligence Welcomes Duncan Emerton, PhD as New Director at Informa Pharma Consulting

Leading pharma and healthcare consulting group brings on new director

LONDON, June 03, 2019 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence today announced that Duncan Emerton, PhD has joined the team in the position of Director. A global expert in biosimilars and the pharmaceutical/biotech space, Dr. Emerton is also a well-known speaker and thought-leader with an established reputation within the healthcare markets Informa Pharma Intelligence serves.

Dr. Emerton has more than 20 years of experience in the pharmaceutical industry, spanning roles in non-clinical and clinical R&D, sales, marketing, medical affairs, strategic consulting and business analysis. Most recently, Duncan was at FirstWord Group, where he was responsible for all syndicated disease analysis across a wide range of therapy areas, including respiratory, autoimmune, neurology, rare diseases and oncology.

“Much of my career has focused on working for and partnering with biopharma clients, including supporting strategy, research and bespoke consulting deliverables across varied market intelligence needs. In this new role within Informa Pharma Intelligence, I’m looking forward to supporting clients by utilizing Informa’s industry-leading data to deliver powerful intelligence solutions, strategy development needs, market research and much more.” said Dr. Emerton. More..

Media Contact   
Diffusion PR for Informa Pharma Intelligence
informapharma@diffusionpr.com 
646.571.0120

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.